Navigation Links
Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
Date:8/19/2007

ystar Bio-Pharmaceutical Company is a China-based producer and distributor of veterinary medication, vaccines, micro-organisms and 100% organic herbal feed additives to cure and prevent disease in poultry, livestock, birds and pets. The company's product line consists of more than 80 state-of-the-art products with over 50 additional products in the developmental stage. Skystar has formed strategic sales distribution networks throughout China. Skystar recently completed construction of new state-of-the- art Bio-Pharmaceutical facilities covering an area of almost eight acres. The new facilities meet or exceed all Good Manufacturing Practice (GMP) Certification Standards and have received GMP Certification from the Chinese government. For additional information, please visit http://www.skystarbio-pharmaceutical.com.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995:

Certain statements in this press release and oral statements made by Skystar on its conference call in relation to this release, constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Such factors include, but are not limited to uncertainties in product demand, the impact of competitive products and pricing, the Company's ability to obtain regulatory approvals, changing economic conditions around the world, release and sales of new products and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, fu
'/>"/>

SOURCE Skystar Bio-Pharmaceutical Co.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...Symbol: MS, EDMONTON, Oct. 3 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) for the,Company,s U.S. piv...8298),in patients with secondary progressive MS ha... the trial continue as per the protocol., This wa...
(Date:10/3/2008)...or Ap3ana, CTI,s ,personalized medicine, venture, ...erapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ...t recently President and COO of a Tyr Pharma and f...mics Institute of the Novartis Research,Foundation... Bresso, Italy,CTI Europe currently conducts the ...
(Date:10/2/2008)...2 /- Helix BioPharma,Corp. ... its private,placement announced on September 30, ...ss proceeds totaling CDN$11,424,000., Each unit c...mmon share,purchase warrant, with each whole commo...urchase, subject to adjustment, one common share a...
(Date:10/2/2008)...Provides Business Update to Investors, WILMINGTON...today at an,investor conference, DuPont Vice Presi...ny,s plans to bring its two advanced biofuels prog... technical progress toward the,commercialization o...stocks,economically into biofuels., "Biobutanol a...
Breaking Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
...Taxpayer Bill of Rights proposal are aiming direct...venue limits on state, county, and municipal gover...ss climate. , ,TABOR, they say, places economic de... in jeopardy. , ,Based in part on Colorado,s TABOR...ent would be handcuffed should the measure be enac...
...ay be a flat state, but at BIO 2006 in Chicago it,... hope will draw people from across the exhibition ...wer with lighted displays, which Forward Wisconsi... in Madison before the April 9-12 event. , ,Jan Al...sconsin, is coordinating company involvement in th...
...n as an emerging biotechnology hot spot will be fu...epresented at one of the world,s premier biotechno...e hope. , ,Wisconsin attendees will make up 1.5 pe...ogy Industry Organization,s International Conventi...ormick Place Convention Center. That,s more than m...
... a day when the fledgling Biomedical Technology Al...lity, receiving $500,000 from the Wisconsin Dept. ...s, it was an anecdote from a chemistry professor t...r collaboration between academic researchers. , ,I...stitutional partnerships that are expected to resu...
Other Biology Technology:Critics say tax limits could handcuff tech investment 2Critics say tax limits could handcuff tech investment 3Critics say tax limits could handcuff tech investment 4Critics say tax limits could handcuff tech investment 5State pavilion goes for height, style at BIO expo 2Wisconsin to show up at BIO in numbers 2Wisconsin to show up at BIO in numbers 3Alliance looks to create the right chemistry in SE Wisconsin 2Alliance looks to create the right chemistry in SE Wisconsin 3
(Date:10/3/2008)...he appointment of Esin Gulari, dean of the College... to serve on the National Science Board (NSB). Pre...t along with six other distinguished scientists. ,...st and an engineer," said Gulari. "On the NSB, I w...on a national level. I hope that my participation ...
(Date:10/3/2008)...idies of cellulosic ethanol production and use hav...o an international group of scientists which inclu...d Oklahoma State University. , The 23-member gr...ce-based policy to address this global issue for t...ce, OU botany professor, and Michael Palmer, OSU b...
(Date:10/3/2008)...conspicuous traits produced by melanin pigments (f... some birds and fishes). These traits are used as ...ibute to increase the mating opportunities. Howeve...ds on the fact that they transmit honest informati...only assured by the fact that producing or maintai...
(Date:10/3/2008)...posture and exercise power is due to humans, evolu...iversity of New South Wales (UNSW). , Prehistori...what is perceived as their "turf" and ostracising ...onplace in everyday work situations than many of u...was carried out in hospitals. , "This tribal cul...
Breaking Biology News(10 mins):US Senate confirms Clemson University engineering Dean Esin Gulari to National Science Board 2Oklahoma researchers support biodiversity in biofuels production 2Traits produced by melanin may signal the bearer's capacity to combat free radicals 2Why your boss is white, middle-class and a show-off 2Symposium on energy research highlights future challenges opportunities 2819 1Symposium on energy research highlights future challenges opportunities 2819 2Manufactured Buckyballs dont harm microbes that clean the environment 2817 1Manufactured Buckyballs dont harm microbes that clean the environment 2817 2Manufactured Buckyballs dont harm microbes that clean the environment 2817 3Manufactured Buckyballs dont harm microbes that clean the environment 2817 4Northwest Hospital 26 Medical Center Earns Distinguished Hospital Award for Patient Safety 16276 1Northwest Hospital 26 Medical Center Earns Distinguished Hospital Award for Patient Safety 16276 2Northwest Hospital 26 Medical Center Earns Distinguished Hospital Award for Patient Safety 16276 3Lupus Webchat April 9 Features Ask the Doctor Open Forum 16274 1Lupus Webchat April 9 Features Ask the Doctor Open Forum 16274 2
...d smoking have a high rate of co-occurrence in the...e co-morbidity of alcoholism and smoking among Ame... Clinical & Experimental Research , researcher...g Plains American Indians, as well as the influenc...ional polymorphism called Val158Met may have on th...
...h self-assembly technique for growing replacement ...ntire articular surface of knees damaged by arthri... Musculoskeletal Bioengineering Laboratory, is des... Engineering. , "This has significant ramification...rst time, about the potential treatment of entire ...
... microbiology textbook aimed at undergraduate stud... Written by eminent scientists with practical te...Microbe, will engage students in the learning proc...ique perspective of the field. , "Our working plan...gh facts have a tendency to creep in," says Moseli...
...s have just learned another lesson from nature. Af...eate self-medications, such as anti-fungal agents,...entists already knew that a particular enzyme was ...oncoctions to generate a large family of medically...ducts. The question was, how do they do it? , Che...
Other Biology News:Alcoholism, smoking and genetics among Plains American Indians 2Alcoholism, smoking and genetics among Plains American Indians 3Rice bioengineers pioneer techniques for knee repair 2Microbiology text tells stories, offers online resources 2MIT chemist discovers secret behind nature's medicines 2